Oruka Therapeutics, Inc. (ORKA) Net income 2016–2025
Oruka Therapeutics, Inc. (ORKA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$105.4MFY2025 · since FY2016: -$16.4M → -$105.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$105.4M | -25.9% |
| FY2024 | -$83.7M | -1468.2% |
| FY2023 | -$5.3M | +46.2% |
| FY2022 | -$9.9M | +48.6% |
| FY2021 | -$19.3M | -98.4% |
| FY2020 | -$9.7M | -77.6% |
| FY2019 | -$5.5M | +30.9% |
| FY2018 | -$7.9M | +57.1% |
| FY2017 | -$18.5M | -12.4% |
| FY2016 | -$16.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice